New theranostic approach effectively detects and treats neuroendocrine prostate cancer
A novel theranostic approach that targets RET—a newly identified biomarker for neuroendocrine prostate cancer—enables high-contrast PET imaging and effective, safe treatment for this highly aggressive malignancy. Because ...
Jun 2, 2026
0
2









